(MedPage Today) — A pooled analysis of randomized trials in colon cancer identified a benchmark representing a “clinically relevant definition of cure,” researchers said.
Looking at 15 phase III trials, colon cancer relapse risk fell to 0.5…
Source link : https://www.medpagetoday.com/oncology/coloncancer/117760
Author :
Publish date : 2025-10-02 18:52:00
Copyright for syndicated content belongs to the linked Source.
